Mary Jo Lechowicz, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (114 ratings)

Role

Hematology Oncology
Specialty

Lymphoma
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2003

Call 404-778-0519

Background

Board certified in medical oncology, Mary Jo Lechowicz, MD, has clinical and research interests in hematologic malignancies. Dr. Lechowicz has been a principal investigator and co-principal investigator on a number of national and international clinical trials involving the treatment of patients with virally related cancers, particularly T-cell non-Hodgkin lymphoma in particular. She joined Emory from the Sidney Kimmel Cancer Center at Johns Hopkins University where she completed a post-doctoral fellowship in oncology.

Dr. Lechowicz earned her medical degree from SUNY-Syracuse in Syracuse, New York. She completed her internship and residency at Columbia Presbyterian Medical Center in New York, New York where she was also a Chief Resident. She then completed a fellowship at the Sidney Kimmel Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland.

Titles & Roles

Professor and Vice Chair for Education, Department of Hematology and Medical Oncology

Emory University School of Medicine
Margaret H. Rollins Chair in Cancer

Winship Cancer Institute of Emory University

Education & Training

Education

Fellowship, Medical Oncology, 2003
John Hopkins Bayview Medical Ctr
Residency, Internal Medicine, 1999
Columbia Presbyterian Med Ctr
Internship, Internal Medicine, 1997
Columbia Presbyterian Med Ctr
Medical Education, MD, 1996
SUNY - Syracuse

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2004

Professional Memberships

Dr. Lechowicz is currently active in the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, the American Association of Medical Colleges and the American Association of Cancer Research. She is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.

Research

Publications

Title/Journal	Authors	Publication Date
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry. Blood advances	SK Pierson, JD Brandstadter, DA Torigian, A Bagg, MJ Lechowicz, D Alapat, C Casper, A Chadburn, S Chandrakasan, A Dispenzieri, A Fosså, C Hoffmann, M Ide, R Kurzrock, S Mukherjee, S Nasta, JT Navarro, A Noy, E Oksenhendler, MS Bustamante, S Shyamsundar, M Streetly, RSM Wong, L Zhang, MS Lim, G Srkalovic, F van Rhee, DC Fajgenbaum	04/22/2025
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome. Journal of the American Academy of Dermatology	A Goyal, D O'Leary, B Dabaja, WK Weng, J Zain, C Cutler, J Guitart, YH Kim, LJ Geskin, RT Hoppe, LD Wilson, AW Beaven, S Horwitz, PB Allen, SK Barta, K Bohjanen, JE Brammer, JB Carter, N Comfere, JA DeSimone, K Dusenbery, M Duvic, A Huen, D Jagadeesh, CR Kelsey, MS Khodadoust, MJ Lechowicz, N Mehta-Shah, AJ Moskowitz, EA Olsen, C Poh, B Pro, C Querfeld, C Sauter, L Sokol, O Sokumbi, RA Wilcox, JA Zic, A Gru, M Hamadani, F Foss	04/06/2025
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and cellular therapy	A Goyal, D O'Leary, B Dabaja, WK Weng, J Zain, C Cutler, J Guitart, YH Kim, LJ Geskin, RT Hoppe, LD Wilson, AW Beaven, S Horwitz, PB Allen, SK Barta, K Bohjanen, JE Brammer, JB Carter, N Comfere, JA DeSimone, K Dusenbery, M Duvic, A Huen, D Jagadeesh, CR Kelsey, MS Khodadoust, MJ Lechowicz, N Mehta-Shah, AJ Moskowitz, EA Olsen, C Poh, B Pro, C Querfeld, C Sauter, L Sokol, O Sokumbi, RA Wilcox, JA Zic, M Hamadani, F Foss	11/01/2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease. Haematologica	MS Bustamante, SK Pierson, Y Ren, A Bagg, JD Brandstadter, G Srkalovic, N Mango, D Alapat, MJ Lechowicz, H Li, F Van Rhee, MS Lim, DC Fajgenbaum	07/01/2024
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis. International journal of hematology	MJ Lechowicz, C Smith, R Ristuccia, K Dwyer	06/01/2024
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica	SP Iyer, A Huen, WZ Ai, D Jagadeesh, MJ Lechowicz, C Okada, TA Feldman, P Ghione, JP Alderuccio, R Champion, SH Kim, A Mohrbacher, KV Routhu, P Barde, AM Nair, BM Haverkos	01/01/2024
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature. CNS oncology	JD Preston, CS Jansen, S Kosaraju, T Niyogusaba, TZ Zhuang, SW Iwamoto, SK Hutto, MJ Lechowicz, PB Allen	12/01/2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes. Blood advances	SK Pierson, MS Lim, G Srkalovic, JD Brandstadter, M Sarmiento Bustamante, S Shyamsundar, N Mango, C Lavery, B Austin, D Alapat, MJ Lechowicz, A Bagg, H Li, C Casper, F van Rhee, DC Fajgenbaum	11/14/2023
Ongoing symptoms following complete surgical excision in unicentric Castleman disease. American journal of hematology	M Sarmiento Bustamante, S Shyamsundar, FR Coren, A Bagg, G Srkalovic, D Alapat, F van Rhee, MS Lim, MJ Lechowicz, JD Brandstadter, SK Pierson, DC Fajgenbaum	11/01/2023
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study. Clinical lymphoma, myeloma & leukemia	TZ Zhuang, A McCook-Veal, J Switchenko, T Niyogusaba, ES Tarabadkar, K Baird, C O'Leary, D Paulino, MJ Lechowicz, PB Allen	09/01/2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. British journal of haematology	R Stuver, SM Horwitz, RH Advani, JM Vose, HJ Lee, N Mehta-Shah, JM Zain, B Haverkos, MJ Lechowicz, AJ Moskowitz, LQ Pham, E Leyden, SM Ansell, MA Lunning	08/01/2023
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia. Leukemia & lymphoma	PB Allen, S Goyal, J Switchenko, E Tarabadkar, S Pouch, P Parikh, A Palmer, D Martini, E Kim, MJ Lechowicz	03/01/2023
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study. Cancer	PB Allen, AA McCook-Veal, JM Switchenko, DM Paulino, T Niyogusaba, KM Baird, ES Tarabadkar, MJ Lechowicz	02/15/2023
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies. Cancer research communications	A Chang, A Akhtar, L Lai, VM Orellana-Noia, SL Linderman, AA McCook-Veal, JM Switchenko, M Saini, RM Valanparambil, KA Blum, PB Allen, MJ Lechowicz, JT Romancik, A Ayers, A Leal, CB O'Leary, MC Churnetski, K Baird, M Kives, J Wrammert, AK Nooka, JL Koff, MV Dhodapkar, MS Suthar, JB Cohen, R Ahmed	12/01/2022
Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome. JAMA dermatology	PB Allen, S Goyal, T Niyogusaba, C O'Leary, A Ayers, ES Tarabadkar, MK Khan, MJ Lechowicz	11/01/2022
CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. Clinical lymphoma, myeloma & leukemia	A Chang, L Lai, A Akhtar, S Linderman, V Orellana-Noia, M Saini, R Valanparambil, K Blum, P Allen, M Lechowicz, J Romancik, A Ayers, C O'Leary, M Churnetski, M Kives, A Nooka, J Koff, M Dhodapkar, M Suthar, J Cohen, R Ahmed	09/27/2022
African American and Caucasian patients with Sézary syndrome have no differences in outcomes at an ethnically diverse urban medical center. Leukemia & lymphoma	DJ Martini, S Goyal, JM Switchenko, MJ Lechowicz, PB Allen	09/01/2022
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood	EA Olsen, S Whittaker, R Willemze, L Pinter-Brown, F Foss, L Geskin, L Schwartz, S Horwitz, J Guitart, J Zic, YH Kim, GS Wood, M Duvic, W Ai, M Girardi, A Gru, E Guenova, E Hodak, R Hoppe, W Kempf, E Kim, MJ Lechowicz, P Ortiz-Romero, E Papadavid, P Quaglino, M Pittelkow, HM Prince, JA Sanches, M Sugaya, M Vermeer, J Zain, R Knobler, R Stadler, M Bagot, J Scarisbrick	08/04/2022
The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry. British journal of haematology	DC Fajgenbaum, SK Pierson, K Kanhai, A Bagg, D Alapat, MS Lim, MJ Lechowicz, G Srkalovic, TS Uldrick, F van Rhee	07/01/2022
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma. Annals of hematology	M Krishnan, RG Bociek, M Fanale, SP Iyer, MJ Lechowicz, PJ Bierman, JO Armitage, M Lunning, A Kallam, JM Vose	02/01/2022
Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis. European journal of cancer (Oxford, England : 1990)	PB Allen, S Goyal, C O'Leary, A Ayers, T Niyogusaba, MK Khan, MJ Lechowicz	10/01/2021
T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma. JAMA dermatology	JA Marks, JM Switchenko, DJ Martini, ES Tarabadkar, MK Khan, MJ Lechowicz, PB Allen	08/01/2021
Nivolumab-associated cutaneous T-cell lymphoma. JAAD case reports	JA Marks, DC Parker, LC Garrot, MJ Lechowicz	03/01/2021
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood advances	F van Rhee, E Oksenhendler, G Srkalovic, P Voorhees, M Lim, A Dispenzieri, M Ide, S Parente, S Schey, M Streetly, R Wong, D Wu, I Maillard, J Brandstadter, N Munshi, W Bowne, KS Elenitoba-Johnson, A Fössa, MJ Lechowicz, S Chandrakasan, SK Pierson, A Greenway, S Nasta, K Yoshizaki, R Kurzrock, TS Uldrick, C Casper, A Chadburn, DC Fajgenbaum	12/08/2020
Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. American journal of hematology	DC Fajgenbaum, D Wu, A Goodman, R Wong, A Chadburn, S Nasta, G Srkalovic, S Mukherjee, H Leitch, R Jayanthan, S Ferrero, Y Sato, S Schey, A Dispenzieri, E Oksenhendler, PL Zinzani, MJ Lechowicz, C Hoffmann, N Pemmaraju, A Bagg, A Fossa, MS Lim, F van Rhee	12/01/2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy. Clinical lymphoma, myeloma & leukemia	MR Kudelka, JM Switchenko, MJ Lechowicz, N Esiashvili, CR Flowers, MK Khan, PB Allen	11/01/2020
Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL). Leukemia & lymphoma	PB Allen, J Switchenko, A Ayers, E Kim, MJ Lechowicz	11/01/2020
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. Cancers	A Huen, BM Haverkos, J Zain, R Radhakrishnan, MJ Lechowicz, S Devata, NJ Korman, L Pinter-Brown, Y Oki, PJ Barde, A Nair, KV Routhu, S Viswanadha, S Vakkalanka, SP Iyer	08/15/2020
Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab. JAAD case reports	SA Westergaard, MJ Lechowicz, M Harrington, J Elsey, JL Arbiser, MK Khan	08/01/2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia. Cancer	L Clough, AR Bayakly, KC Ward, MK Khan, SC Chen, MJ Lechowicz, CR Flowers, PB Allen, JM Switchenko	04/15/2020
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Cancer	JB Cohen, L Wei, KJ Maddocks, B Christian, LT Heffner, AA Langston, MJ Lechowicz, P Porcu, CR Flowers, SM Devine, KA Blum	03/15/2020
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry. Acta haematologica	F Lansigan, SM Horwitz, LC Pinter-Brown, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, AR Shustov, RH Advani, T Feldman, MJ Lechowicz, SM Smith, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	01/01/2020
Management of NK/T-Cell Lymphoma, Nasal Type. Journal of oncology practice	PB Allen, MJ Lechowicz	10/01/2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Cancer	SI Park, SM Horwitz, FM Foss, LC Pinter-Brown, KR Carson, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, RH Advani, T Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, AR Shustov	05/01/2019
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. The Lancet. Haematology	K Dunleavy, MA Fanale, JS Abramson, A Noy, PF Caimi, S Pittaluga, S Parekh, A Lacasce, JW Hayslip, D Jagadeesh, S Nagpal, MJ Lechowicz, R Gaur, A Lucas, C Melani, M Roschewski, SM Steinberg, ES Jaffe, B Kahl, JW Friedberg, RF Little, NL Bartlett, WH Wilson	12/01/2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood	F van Rhee, P Voorhees, A Dispenzieri, A Fosså, G Srkalovic, M Ide, N Munshi, S Schey, M Streetly, SK Pierson, HL Partridge, S Mukherjee, D Shilling, K Stone, A Greenway, J Ruth, MJ Lechowicz, S Chandrakasan, R Jayanthan, ES Jaffe, H Leitch, N Pemmaraju, A Chadburn, MS Lim, KS Elenitoba-Johnson, V Krymskaya, A Goodman, C Hoffmann, PL Zinzani, S Ferrero, L Terriou, Y Sato, D Simpson, R Wong, JF Rossi, S Nasta, K Yoshizaki, R Kurzrock, TS Uldrick, C Casper, E Oksenhendler, DC Fajgenbaum	11/15/2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. British journal of haematology	M Federico, M Bellei, L Marcheselli, M Schwartz, M Manni, V Tarantino, S Pileri, YH Ko, ME Cabrera, S Horwitz, WS Kim, A Shustov, FM Foss, A Nagler, K Carson, LC Pinter-Brown, S Montoto, M Spina, TA Feldman, MJ Lechowicz, SM Smith, F Lansigan, R Gabus, JM Vose, RH Advani	06/01/2018
Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas. Cancer management and research	PB Allen, MJ Lechowicz	01/01/2018
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer	KR Carson, SM Horwitz, LC Pinter-Brown, ST Rosen, B Pro, ED Hsi, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, MA Acosta, AR Shustov, RH Advani, TA Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	04/01/2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clinical lymphoma, myeloma & leukemia	ED Hsi, SM Horwitz, KR Carson, LC Pinter-Brown, ST Rosen, B Pro, M Federico, C Gisselbrecht, M Schwartz, LA Bellm, M Acosta, AM Collie, AM Gruver, BJ Grzywacz, S Turakhia, AR Shustov, RH Advani, T Feldman, MJ Lechowicz, SM Smith, F Lansigan, A Tulpule, MD Craig, JP Greer, BS Kahl, JW Leach, N Morganstein, C Casulo, SI Park, FM Foss	04/01/2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood	DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, D Simpson, AY Liu, D Menke, S Chandrakasan, MJ Lechowicz, RS Wong, S Pierson, M Paessler, JF Rossi, M Ide, J Ruth, M Croglio, A Suarez, V Krymskaya, A Chadburn, G Colleoni, S Nasta, R Jayanthan, CS Nabel, C Casper, A Dispenzieri, A Fosså, D Kelleher, R Kurzrock, P Voorhees, A Dogan, K Yoshizaki, F van Rhee, E Oksenhendler, ES Jaffe, KS Elenitoba-Johnson, MS Lim	03/23/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
T-cell Lymphoma Epidemiology: the Known and Unknown. Current hematologic malignancy reports	A Phan, R Veldman, MJ Lechowicz	12/01/2016
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome. Leukemia & lymphoma	HH Danish, S Liu, J Jhaveri, CR Flowers, MJ Lechowicz, N Esiashvili, MK Khan	12/01/2016
Human immunodeficiency virus lymphomas in the era of antiretrovirals: Is it finally time to change the discussion? Cancer	CJ Gunthel, MJ Lechowicz	09/01/2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	OW Press, H Li, H Schöder, DJ Straus, CH Moskowitz, M LeBlanc, LM Rimsza, NL Bartlett, AM Evens, ES Mittra, AS LaCasce, JW Sweetenham, PM Barr, MA Fanale, MV Knopp, A Noy, ED Hsi, JR Cook, MJ Lechowicz, RD Gascoyne, JP Leonard, BS Kahl, BD Cheson, RI Fisher, JW Friedberg	06/10/2016
CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation. Dermatology and therapy	HH Danish, TR Heumann, KT Bradley, J Switchenko, N Esiashvili, MJ Lechowicz, CR Flowers, MK Khan	06/01/2016
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British journal of haematology	RH Advani, SM Ansell, MJ Lechowicz, AW Beaven, F Loberiza, KR Carson, AM Evens, F Foss, S Horwitz, B Pro, LC Pinter-Brown, SM Smith, AR Shustov, KJ Savage, JM Vose	02/01/2016
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. British journal of haematology	JB Cohen, JM Switchenko, JL Koff, R Sinha, JL Kaufman, HJ Khoury, N Bumpers, A Colbert, A Hutchison-Rzepka, LJ Nastoupil, LT Heffner, AA Langston, MJ Lechowicz, S Lonial, CR Flowers	11/01/2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion	N Jagirdar, RD Harvey, A Nooka, C Flowers, J Kaufman, S Lonial, MJ Lechowicz, A Langston, C Lipscomb, C Gaylor, EK Waller	10/01/2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia	JB Cohen, S Bucur, EF Winton, R Sinha, LT Heffner, N King, S Lonial, AA Langston, EK Waller, A Hutchison-Rzepka, A Colbert, MJ Lechowicz, CR Flowers	09/01/2015
Clinical development of siltuximab. Current oncology reports	CC Davis, KS Shah, MJ Lechowicz	07/01/2015
Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. International journal of radiation oncology, biology, physics	TR Heumann, N Esiashvili, S Parker, JM Switchenko, A Dhabbaan, M Goodman, MJ Lechowicz, CR Flowers, MK Khan	05/01/2015
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & lymphoma	LJ Nastoupil, PJ Shenoy, A Ambinder, JL Koff, AK Nooka, EK Waller, A Langston, M Seward, JL Kaufman, L Bernal-Mizrachi, N King, MJ Lechowicz, S Lonial, R Sinha, CR Flowers	02/01/2015
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome. Bone marrow transplantation	MJ Lechowicz, HM Lazarus, J Carreras, GG Laport, CS Cutler, PH Wiernik, GA Hale, D Maharaj, RP Gale, PA Rowlings, CO Freytes, AM Miller, JM Vose, RT Maziarz, S Montoto, DG Maloney, PN Hari	11/01/2014
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Report of 2 Cases and Review of the Literature. Aesthetic surgery journal	AM Hart, MJ Lechowicz, KK Peters, J Holden, GW Carlson	08/01/2014
Right ventricular myocarditis and its deceptive electrical signal. International journal of cardiology	PT Strickland, GR Hartlage, MJ Lechowicz, SD Clements	07/15/2014
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone marrow transplantation	AA Langston, JM Prichard, S Muppidi, A Nooka, MJ Lechowicz, S Lonial, R Sinha, M Graiser, JL Kaufman, HJ Khoury, CR Flowers, EK Waller	02/01/2014
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia	R Sinha, PJ Shenoy, N King, MJ Lechowicz, K Bumpers, D Hutcherson, M Arellano, A Langston, J Kaufman, LT Heffner, EK Waller, A Nooka, CR Flowers, S Lonial	12/01/2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	RD Harvey, JL Kaufman, HR Johnson, A Nooka, L Vaughn, CR Flowers, HJ Khoury, MJ Lechowicz, AA Langston, S Lonial, EK Waller	09/01/2013
Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leukemia & lymphoma	MH Imam, PJ Shenoy, CR Flowers, A Phillips, MJ Lechowicz	04/01/2013
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Akhtari, J Kaufman, C Torre, MJ Lechowicz, C Flowers, R Sinha, HJ Khoury, AA Langston, EK Waller	03/01/2013
Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leukemia & lymphoma	CR Flowers, PJ Shenoy, U Borate, K Bumpers, T Douglas-Holland, N King, OW Brawley, J Lipscomb, MJ Lechowicz, R Sinha, RS Grover, L Bernal-Mizrachi, J Kowalski, W Donnellan, A The, V Reddy, DL Jaye, J Foran	02/01/2013
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion	JL Kaufman, CR Flowers, KD Rados, GB Calandra, JM Vose, LB Hewes, S Lonial, AA Langston, HJ Khoury, MJ Lechowicz, EK Waller	01/01/2013
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. British journal of haematology	D Muringampurath-John, DL Jaye, CR Flowers, D Saxe, Z Chen, MJ Lechowicz, DD Weisenburger, M Bast, ML Arellano, L Bernal-Mizrachi, LT Heffner, M McLemore, JL Kaufman, EF Winton, S Lonial, JO Armitage, HJ Khoury	09/01/2012
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas. Cancer	R Sinha, JL Kaufman, HJ Khoury, N King, PJ Shenoy, C Lewis, K Bumpers, A Hutchison-Rzepka, M Tighiouart, LT Heffner, MJ Lechowicz, S Lonial, CR Flowers	07/15/2012
Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. Leukemia & lymphoma	D Muringampurath-John, CR Flowers, M Toscano, C Zhengjia, JL Kaufman, M Arellano, L Bernal-Mizrachi, LT Heffner, MJ Lechowicz, M McLemore, E Winton, DL Jaye, S Lonial, HJ Khoury	04/01/2012
Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease. Current drug delivery	E Reid, A Nooka, J Blackmon, MJ Lechowicz	01/01/2012
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion	J Li, E Hamilton, L Vaughn, M Graiser, H Renfroe, MJ Lechowicz, A Langston, JM Prichard, D Anderson, C Gleason, S Lonial, CR Flowers, JL Kaufman, EK Waller	10/01/2011
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN hematology	AN Abouyabis, PJ Shenoy, R Sinha, CR Flowers, MJ Lechowicz	01/01/2011
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion	M Akhtari, CR Giver, Z Ali, CR Flowers, CL Gleason, CD Hillyer, J Kaufman, HJ Khoury, AA Langston, MJ Lechowicz, S Lonial, HM Renfroe, JD Roback, M Tighiouart, L Vaughn, EK Waller	11/01/2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clinical cancer research : an official journal of the American Association for Cancer Research	S Lonial, J Kaufman, M Tighiouart, A Nooka, AA Langston, LT Heffner, C Torre, S McMillan, H Renfroe, RD Harvey, MJ Lechowicz, HJ Khoury, CR Flowers, EK Waller	10/15/2010
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits? Clinical lymphoma, myeloma & leukemia	P Shenoy, R Sinha, JW Tumeh, MJ Lechowicz, CR Flowers	08/01/2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia & lymphoma	H Tran, M Arellano, A Chamsuddin, C Flowers, LT Heffner, A Langston, MJ Lechowicz, A Tindol, E Waller, EF Winton, HJ Khoury	08/01/2010
A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. American journal of clinical pathology	SD Schniederjan, S Li, DF Saxe, MJ Lechowicz, KL Lee, PD Terry, KP Mann	05/01/2010
Nasal NK/T-cell lymphoma: where are we now? Oncology (Williston Park, N.Y.)	MJ Lechowicz	04/15/2010
HIV-K: an integrative knowledge base for semantic integration of AIDS-related malignancy data and treatment outcomes. Studies in health technology and informatics	A Tirado-Ramos, J Saltz, MJ Lechowicz	01/01/2010
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	M Lechowicz, DP Dittmer, JY Lee, SE Krown, W Wachsman, D Aboulafia, BJ Dezube, L Ratner, J Said, RF Ambinder	12/15/2009
Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine	W Zeng, MJ Lechowicz, E Winton, SM Cho, JR Galt, R Halkar	06/01/2009
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leukemia & lymphoma	AN Abouyabis, PJ Shenoy, MJ Lechowicz, CR Flowers	11/01/2008
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone marrow transplantation	S Murali, E Winton, EK Waller, LT Heffner, S Lonial, C Flowers, J Kaufman, M Arellano, MJ Lechowicz, KP Mann, HJ Khoury, AA Langston	10/01/2008
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & lymphoma	S Lonial, M Arellano, D Hutcherson, A Langston, C Flowers, LT Heffner, E Winton, M Jo Lechowicz, EK Waller	10/01/2006

Awards

Exemplary Teacher of the Year Award, Emory University, 2019
Dean's Teaching Award, Emory University School of Medicine, 2018-2019
Dean's Teaching Award, Emory University School of Medicine, 2012-2013
Emory University School of Medicine Class of 2013, Senior Superlatives Awards – Student Elected
"Doctor who could take care of your Grandmother"
Named "The Dr. Mary Jo Lechowicz Award", 2013
Emory University School of Medicine Class of 2011, Senior Superlatives Awards – Student Elected
"Doctor whom you would take your family to in medical subspecialties"
Named "The Dr. Mary Jo Lechowicz Award", 2011

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	05/09/2025	I believe Dr. Lechowicz has literally saved my life.
One star One star One star One star One star	04/28/2025	Wonderful doctor.
One star One star One star One star One star	04/21/2025	Dr. Lechowicz is the best, can't say enough about her.
One star One star One star One star One star	04/06/2025	Dr. Lechowicz is friendly, responsive to questions and concerns, takes her time and medically knowledgeable and provides test result explanations that are understandable.
One star One star One star One star One star	03/25/2025	Dr. Lechowicz truly listened to my concerns. I felt heard and understood.
One star One star One star One star One star	03/24/2025	Dr Lechowicz is a fantastic doctor. She listens to my questions, answers in terms I can understand and has a sincere interest in her patients.
One star One star One star One star One star	03/18/2025	Absolutely love Dr. Lechowicz, nurses, and her lab staff.
One star One star One star One star One star	03/18/2025	Dr Lechowicz is great!
One star One star One star One star One star	03/16/2025	Dr. Lechowicz is the very best!
One star One star One star One star One star	03/11/2025	Our doctor comes highly recommended. She gave us hope.
One star One star One star One star One star	03/03/2025	Both the assistant and doctor were easy to converse with. I answered questions and voiced my opinion.
One star One star One star One star One star	01/19/2025	Very good empathy and sense of urgency
One star One star One star One star One star	01/08/2025	Marry Jo is the best!
One star One star One star One star One star	12/15/2024	Excellent
One star One star One star One star One star	11/23/2024	Dr Mary Jo Lechovich was amazing! She was knowledgeable, compassionate, and I felt fortunate to have her as my physician.
One star One star One star One star One star	11/09/2024	She answered all my questions and concerns! I find her to be kind and thoughtful for my condition!
One star One star One star One star One star	10/22/2024	Excelente
One star One star One star One star One star	10/18/2024	I would definitely recommend my care provider to family and friends. Always there when I need her.
One star One star One star One star One star	10/18/2024	Lechowicz is one of the best doctors at EHC
One star One star One star One star One star	10/05/2024	I was very happy with my experience and I am delighted with Dr. Lechowicz.
One star One star One star One star One star	10/02/2024	Dr.Lechowitz has been my oncologist since 2020, and her professional and bedside matter is top-notch.
One star One star One star One star One star	09/22/2024	Excellent physician
One star One star One star One star One star	08/26/2024	Dr. Lechowicz is absolutely the best of the best.
One star One star One star One star One star	08/17/2024	Dr Lechowicz is a phenomenal Doctor. Her interest in me as her patient and interest in me as a person is outstanding. I cannot say enough positive things about her as a physician. She is quite a roll model for your younger doctors and staff.
One star One star One star One star One star	07/30/2024	Good experience
One star One star One star One star One star	07/27/2024	Excellent service.
One star One star One star One star One star	06/28/2024	Have been seeing Dr Lechowicz for some time and, as usual, she was very personable as well as professional.
One star One star One star One star One star	06/21/2024	Arguably the best experience I have had, especially with a new team.